ºüÀêÊÓƵ

Vanderbilt University Medical Center doctors announced today they will begin screening patients who take commonly prescribed statin drugs for a rare genetic variation that can increase risks for side effects from these drugs such as muscle aches, kidney damage and even death. Read More

Study suggests a new therapeutic target in ulcerative colitis. Read More

A growth factor may help grow transplantation-quality pancreas cells for treating diabetes. Read More

Bipolar depression and schizophrenia share patterns of changes in neurons that regulate information flow, new research shows. Read More

The new Center for Diabetes Translation Research will translate scientific breakthroughs into practices that can be applied in the doctor’s office and the patient’s home. Read More

Each year millions of Americans return to the hospital within 30 days of their previous discharge. Although many readmissions could be preventable, most statistical models for predicting them "perform poorly," according to researchers at Vanderbilt and the Oregon Health and Science University and their affiliated VA medical centers. Read More

Supplements did not improve outcomes of patients with acute lung injury. Read More

Antibodies to the 2009 H1N1 influenza strain reveal new insights into how antibody diversity forms and functions, with possible implications for designing flu vaccines. Read More

Structural studies are providing insight to how aflatoxin – a toxin produced by fungi – contributes to cancer development. Read More

A protein critical in heart development may also play a part in colon cancer progression. Read More

Neuronal activity in a deep brain region increases as Parkinson’s disease advances, a new study suggests. Read More

Drug-like molecules described by Vanderbilt researchers could lead to Parkinson's treatments with fewer side effects. Read More

Low folate levels may increase a premenopausal woman’s risk of developing breast cancer. Read More

Vanderbilt University investigators have discovered surprising new insights into the actions of NSAIDs. Read More

A report released by the Institute of Medicine confirms the safety of eight vaccines studied by a committee of experts. Evidence showed no links between immunization and serious conditions that have raised concerns, including Type 1 diabetes and autism. Read More

Should scientists inform participants in genomic studies about their risk for diseases or conditions discovered during the studies, and if so, when and how? A Vanderbilt professor is part of a team working to answer these questions. Read More

The discovery of new compounds that work in a fundamentally different way than those in existing schizophrenia medications may allow for more normal function of brain cells involved in schizophrenia. Read More

Researchers at Vanderbilt University Medical Center, in collaboration with Seaside Therapeutics in Cambridge, Mass., have achieved a milestone in the development of a potential new treatment for fragile X syndrome, the most common genetic cause of autism. Read More

A new study shows ophthalmologic antibiotics promote antimicrobial resistance, prompting a call from Vanderbilt Eye Institute physicians to be more judicial in administering the drugs. Read More

A new study indicates that patients with high-grade glioma brain tumors who have preexisting type 2 diabetes or obesity have poorer outcomes, and is the first to use the Vanderbilt Brain Tumor Center Clinical Database to report a novel clinical finding. Read More